CYTOMX THERAPEUTICS INC's ticker is CTMX and the CUSIP is 23284F105. A total of 115 filers reported holding CYTOMX THERAPEUTICS INC in Q1 2019. The put-call ratio across all filers is 1.75 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $37,000 | +5.7% | 20,054 | +53.1% | 0.00% | 0.0% |
| Q1 2022 | $35,000 | -63.5% | 13,101 | -13.7% | 0.00% | -66.7% |
| Q2 2021 | $96,000 | -87.0% | 15,182 | -84.1% | 0.00% | -89.3% |
| Q1 2021 | $737,000 | +504.1% | 95,284 | +552.9% | 0.03% | +250.0% |
| Q2 2020 | $122,000 | +14.0% | 14,595 | +5.0% | 0.01% | -11.1% |
| Q1 2020 | $107,000 | -29.1% | 13,900 | +39.0% | 0.01% | -59.1% |
| Q4 2018 | $151,000 | – | 10,000 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Burrage Capital Management LLC | 476,110 | $3,956,000 | 2.65% |
| MPM BioImpact LLC | 855,437 | $7,109,000 | 2.52% |
| Exane Asset Management | 87,876 | $730,250,000 | 0.90% |
| Congress Park Capital LLC | 94,661 | $787,000 | 0.58% |
| Perceptive Advisors | 3,253,923 | $27,040,000 | 0.54% |
| BVF INC/IL | 766,148 | $6,367,000 | 0.48% |
| RTW INVESTMENTS, LP | 1,039,593 | $8,639,000 | 0.33% |
| EcoR1 Capital, LLC | 410,000 | $3,407,000 | 0.31% |
| DAFNA Capital Management LLC | 100,000 | $831,000 | 0.28% |
| HARBOURVEST PARTNERS LLC | 79,193 | $658,000 | 0.27% |